Why the study?
Does synthetic human atrial natriuretic peptide reduce reperfusion arrhythmias and improve left ventricular function in patients with anterior AMI undergoing direct coronary angioplasty?
Does synthetic human atrial natriuretic peptide reduce reperfusion arrhythmias and improve left ventricular function in patients with anterior AMI undergoing direct coronary angioplasty?
Administration of hANP during and after direct coronary angioplasty for anterior AMI may attenuate reperfusion arrhythmias and preserve left ventricular function at 6 months.
No takes yet. Share an insight, caveat, or question.
Does not support routine hANP use; leaves open benefit in anterior AMI pending randomized confirmation.
Kuga et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: